In a recent study [16], a two-phase MGMT Promoter Methylation Prediction (MGMT-PMP) system was employed to extract and combine different types of radiomics features (GLCM, HOG, and LBP) to predict GBM subtype using the BraTS-2021 dataset. The gene discussed is MGMT; the disease is glioblastoma.